HEPA · Hepion Pharmaceuticals, Inc. · Executive Compensation
$0.14
-0.18 (-57.55%)
At close · May 13
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to our recurring and expected continuing losses from operations, we have concluded there is substantial doubt in our ability to continue as a going concern within one year of the issuance of these condensed consolidated financial statements without additional capital becoming available to us.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.77M
Shares
90.22M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James Liddy | director | Appointed | 2026-08-20 |
| Gary S. Stetz, II | directors of the Company | Appointed | 2026-07-02 |
| Danina Fisher | directors of the Company | Appointed | 2026-07-02 |
| Dr. Kaouthar Lbiati | director | Resigned | 2026-04-14 |
| Chase LoPriore | director | Appointed | 2026-03-18 |
| Sireesh Appajosyula | director | Appointed | 2026-03-18 |
| Gary Stetz | director | Appointed | 2026-03-18 |
| Vincent LoPriore | Executive Chairman | Appointed | 2026-03-18 |
| Gary Stetz | interim Chief Executive Officer | Appointed | 2026-03-18 |
| Kaouthar Lbiati | Chief Executive Officer | Resigned | 2026-03-18 |
| Dr. Kaouthar Lbiati | Chief Executive Officer | Appointed | 2026-01-15 |
| John Brancaccio | director | Resigned | 2025-06-30 |
| John Brancaccio | CFO | Resigned | 2025-06-30 |
| Kaouthar Lbiati | interim Chief Executive Officer | Appointed | 2025-06-09 |
| John Brancaccio | interim Chief Executive Officer | Appointed | 2024-08-07 |
| John Brancaccio | interim Chief Financial Officer | Appointed | 2024-08-07 |
| Michael Purcell | Chair of the Audit Committee | Appointed | 2024-03-06 |
| Michael Purcell | director | Appointed | 2024-03-06 |
| Dr. Gary Jacob | Chairman of the Board of Directors | Resigned | 2024-02-20 |
| Anand Reddi | Board of Directors | Resigned | 2024-02-07 |
| John Cavan | interim Chief Executive Officer | Appointed | 2023-12-07 |
| Dr. Peter Wijngaard | Board of Directors | Resigned | 2023-12-07 |
| Dr. Robert Foster | Board of Directors | Resigned | 2023-12-07 |
| Dr. Robert Foster | CEO | Resigned | 2023-12-07 |
| Stephen Harrison, M.D. | Consultant Medical Director | Appointed | 2023-09-06 |